US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion NVDA Defined Income Boost ETF

27.37

+0.01270.05%

Post-market: 27.500.1304+0.48%16:10 EDT

Volume:1K

Turnover:32.81K

Market Cap:2.46M

PE:- -

High:27.50

Open:27.40

Low:27.37

Close:27.36

52wk High:28.89

52wk Low:24.54

Shares:90.00K

Float Shares:90.00K

Volume Ratio:3.97

T/O Rate:1.33%

Dividend:0.45

Dividend Rate:1.65%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ideaya Biosciences initiates monotherapy expansion in IDE892 trial

Healios Secures AMED Funding to Industrialize iPSC-Derived NK Cell Therapy

Chinese biotech overtakes AI as emerging-market growth trade

Srinivasan Sivabalan / Bloomberg

Capricor Therapeutics (CAPR) Secures New Headquarters Tied To FDA Decision On Deramiocel

Simply Wall St.

BB Biotech posts strong interim profit and shifts to yield-based dividend policy

South Korea's Q2 GDP Exceeds Expectations, Fueled by AI Chip Export Boom, Adding Pressure for Further Rate Hikes

CSPC Advances HPV mRNA Vaccine SYS6026 to Phase II Trial in China

NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS

Imunon announces new preliminary data from IMNN-001 trial

Biotech IPO gains crush AI listings with standout 55% return

Anthony Hughes / Bloomberg

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/NVIB/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVIB\",,,,,undefined,":{"symbol":"NVIB","market":"US","secType":"STK","nameCN":"Direxion NVDA Defined Income Boost ETF","latestPrice":27.3696,"timestamp":1789156800000,"preClose":27.3569,"halted":0,"volume":1193,"hourTrading":{"tag":"盘后","latestPrice":27.5,"preClose":27.3696,"latestTime":"16:10 EDT","volume":6,"amount":164.2176,"timestamp":1789157404751,"change":0.1304,"changeRate":0.004764,"amplitude":0},"delay":0,"changeRate":0.000464233886149338,"floatShares":90001,"shares":90001,"eps":0,"marketStatus":"Market Closed","change":0.0127,"latestTime":"09-11 16:00:00 EDT","open":27.401,"high":27.5,"low":27.3696,"amount":32812,"amplitude":0.004767,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1785297600000,"exchange":"CBOE","adjPreClose":27.3569,"nav":27.337,"aum":2460334.39,"dividendRate":0.016467,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":27.5,"preClose":27.3696,"latestTime":"16:10 EDT","volume":6,"amount":164.2176,"timestamp":1789157404751,"change":0.1304,"changeRate":0.004764,"amplitude":0},"volumeRatio":3.974015203722743},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVIB\",,,,,undefined,":{"symbol":"NVIB","floatShares":90001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.974015203722743,"shares":90001,"dividePrice":0.4507,"high":27.5,"amplitude":0.004767,"preClose":27.3569,"low":27.3696,"week52Low":24.54,"pbRate":"--","week52High":28.8896,"institutionHeld":0,"latestPrice":27.3696,"eps":0,"divideRate":0.016467,"volume":1193,"delay":0,"ttmEps":0,"open":27.401,"prevYearClose":25,"prevWeekClose":28.8896,"prevMonthClose":27.4504,"prevQuarterClose":25,"fiveDayClose":28.4889,"twentyDayClose":28.3265},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVIB\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"NVIB","amount":0.21733,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-28","defaultRemindTime":1787923800000,"name":"Direxion NVDA Defined Income Boost ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-31","payableDate":"2026-08-28","currency":"USD","dateTimestamp":1787889600000,"payDate":"2026-08-31"},{"date":"2026-08-14","symbol":"NVIB","amount":0.23454,"announcedDate":"2026-08-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-14","defaultRemindTime":1786714200000,"name":"Direxion NVDA Defined Income Boost ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-17","payableDate":"2026-08-14","currency":"USD","dateTimestamp":1786680000000,"payDate":"2026-08-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVIB\",market:\"US\",,,undefined,":[{"executeDate":"2026-08-14","recordDate":"2026-08-14","paymentDate":"2026-08-17","value":0.23454,"currency":"USD"},{"executeDate":"2026-08-28","recordDate":"2026-08-28","paymentDate":"2026-08-31","value":0.21733,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVIB\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654019247","title":"Ideaya Biosciences initiates monotherapy expansion in IDE892 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2654019247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654019247?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:11","pubTimestamp":1785147099,"startTime":"0","endTime":"0","summary":"Ideaya Biosciences (IDYA) announced that initiation of Part 2 monotherapy expansion has been achieved in its Phase 1/2 clinical trial evaluating ID...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ideaya-biosciences-initiates-monotherapy-expansion-in-ide892-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ideaya-biosciences-initiates-monotherapy-expansion-in-ide892-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDYA","HYLG","BK4139","GDOC","IDNA","NVIB","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654509632","title":"Healios Secures AMED Funding to Industrialize iPSC-Derived NK Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654509632","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654509632?lang=en_us&edition=fundamental","pubTime":"2026-07-27 10:52","pubTimestamp":1785120734,"startTime":"0","endTime":"0","summary":"Healios KK ( ($JP:4593) ) has issued an update. Healios K.K., a clinical-stage regenerative medicine biotech in Japan, is developing stem cell-base...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healios-secures-amed-funding-to-industrialize-ipsc-derived-nk-cell-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healios-secures-amed-funding-to-industrialize-ipsc-derived-nk-cell-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","LU1093756168.USD","XBIX","BK4135","LU1093756325.SGD","NVIB","JP","AMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654047803","title":"Chinese biotech overtakes AI as emerging-market growth trade","url":"https://stock-news.laohu8.com/highlight/detail?id=2654047803","media":"Srinivasan Sivabalan / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654047803?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:33","pubTimestamp":1785105227,"startTime":"0","endTime":"0","summary":"As the artificial-intelligence rally sputters in emerging markets, investors searching for high-growth alternatives are turning to Chinese biotech.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/healthcare/chinese-biotech-overtakes-ai-emerging-market-growth-trade?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/healthcare/chinese-biotech-overtakes-ai-emerging-market-growth-trade?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["QQQW","XBIX","KURE","QTOC","AIPO","CHAT","ARTY","NVIB","AGIX","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654062712","title":"Capricor Therapeutics (CAPR) Secures New Headquarters Tied To FDA Decision On Deramiocel","url":"https://stock-news.laohu8.com/highlight/detail?id=2654062712","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654062712?lang=en_us&edition=fundamental","pubTime":"2026-07-27 04:10","pubTimestamp":1785096654,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics signed a lease for a new headquarters and expanded manufacturing facility, contingent on US FDA approval of its Duchenne muscular dystrophy therapy, Deramiocel.\nThe planned space is significantly larger than the company’s current footprint, indicating a move to scale operations once regulatory conditions are met.\n\nCapricor Therapeutics, traded as NasdaqGS:CAPR, is drawing attention with this planned expansion linked directly to a key regulatory milestone. The stock...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-capr/capricor-therapeutics/news/capricor-therapeutics-capr-secures-new-headquarters-tied-to","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-capr/capricor-therapeutics/news/capricor-therapeutics-capr-secures-new-headquarters-tied-to","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GLS.SI","LABU","CFA.SI","SRT.SI","BK4588","BK4585","SRU.SI","JJJ.SI","CAPR","CLR.SI","NVIB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653270989","title":"BB Biotech posts strong interim profit and shifts to yield-based dividend policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2653270989","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653270989?lang=en_us&edition=fundamental","pubTime":"2026-07-24 13:34","pubTimestamp":1784871252,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BB Biotech ( ($CH:BION) ). BB Biotech AG, a specialist biotech investment company listed in Switzerland and Ger...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bb-biotech-posts-strong-interim-profit-and-shifts-to-yield-based-dividend-policy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bb-biotech-posts-strong-interim-profit-and-shifts-to-yield-based-dividend-policy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US6M.BOND","LEAD","NVIB","US2Y.BOND","BK4547","US7Y.BOND","XBI","XBIX","US5Y.BOND","BK4581","VIG","TLT","TLTW","US10Y.BOND","TMF","BK4588","US12M.BOND","US3Y.BOND","BK4585","US30Y.BOND","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173039723","title":"South Korea's Q2 GDP Exceeds Expectations, Fueled by AI Chip Export Boom, Adding Pressure for Further Rate Hikes","url":"https://stock-news.laohu8.com/highlight/detail?id=1173039723","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173039723?lang=en_us&edition=fundamental","pubTime":"2026-07-23 09:46","pubTimestamp":1784771209,"startTime":"0","endTime":"0","summary":"South Korea's economy grew more than anticipated in the second quarter, propelled by an artificial intelligence-driven boom in chip exports, a development that supports the case for the central bank...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINT","MUYY","AMAU","PSAI","NVIB","MUU","INTW","MUZ","MUD","MIC","MULL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653633037","title":"CSPC Advances HPV mRNA Vaccine SYS6026 to Phase II Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2653633037","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653633037?lang=en_us&edition=fundamental","pubTime":"2026-07-22 21:08","pubTimestamp":1784725684,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group ( ($HK:1093) ) has provided an update. CSPC Pharmaceutical Group has officially launched a Phase II clinical trial in Chi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cspc-advances-hpv-mrna-vaccine-sys6026-to-phase-ii-trial-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cspc-advances-hpv-mrna-vaccine-sys6026-to-phase-ii-trial-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","IDNA","NVIB","MEDX","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653768188","title":"NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2653768188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653768188?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:56","pubTimestamp":1784725011,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd. ( ($NRSN) ) just unveiled an update. NeuroSense Therapeutics, a late-stage clinical biotech developer of neurodegenera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurosense-moves-primec-toward-health-canada-drug-submission-for-als?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurosense-moves-primec-toward-health-canada-drug-submission-for-als?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653720383","title":"Imunon announces new preliminary data from IMNN-001 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2653720383","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653720383?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:25","pubTimestamp":1784640328,"startTime":"0","endTime":"0","summary":"Imunon (IMNN) announced new preliminary data from its ongoing Phase 2 minimal residual disease, or MRD, translational clinical trial of IMNN-001, c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/imunon-announces-new-preliminary-data-from-imnn-001-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/imunon-announces-new-preliminary-data-from-imnn-001-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","HYLG","NVIB","BK4139","IDNA","MEDX","IMNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653784051","title":"Biotech IPO gains crush AI listings with standout 55% return","url":"https://stock-news.laohu8.com/highlight/detail?id=2653784051","media":"Anthony Hughes / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653784051?lang=en_us&edition=fundamental","pubTime":"2026-07-21 12:57","pubTimestamp":1784609865,"startTime":"0","endTime":"0","summary":"The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/us-stocks/biotech-ipo-gains-crush-ai-listings-standout-55-return?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/us-stocks/biotech-ipo-gains-crush-ai-listings-standout-55-return?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["BK4127","BK4585","QQQJ","LRCY","IPO","IPOS","BK4581","KCE","VTHR","ARTY","NVIB","PEVC","CHAT","KI","BKIV","AIPO","REDS","IJT","QTOC","FRHC","XBI","XBIX","TMFX","AGIX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":9,"totalSize":170,"code":"91000000","status":"200"}]}}